The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hopper Jonathan Mark since 2020.
This trader's CIK number is 1626325.
At the time of last reporting, Hopper Jonathan Mark was the Chief Medical Officer of Vericel Corp. (stock ticker symbol VCEL).
Also see all insider trading activities at Vericel Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | VCEL | 0 | $0 | 20,000 | $853,000 | 23,000 | $360,000 |
| 2024 | VCEL | 0 | $0 | 30,000 | $1,585,400 | 38,700 | $385,600 |
| 2023 | VCEL | 0 | $0 | 5,000 | $182,000 | 11,350 | $54,750 |
| 2022 | VCEL | 0 | $0 | 16,738 | $693,522 | 24,025 | $289,500 |
| 2021 | VCEL | 0 | $0 | 33,805 | $1,553,357 | 55,713 | $639,391 |
| 2020 | VCEL | 0 | $0 | 24,235 | $642,130 | 43,264 | $473,740 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | VCEL | Option Ex | 10,000 | 18.00 | 180,000 |
| 2025-09-02 | VCEL | Sale | 10,000 | 35.77 | 357,700 |
| 2025-03-03 | VCEL | Option Ex | 10,000 | 18.00 | 180,000 |
| 2025-03-03 | VCEL | Sale | 10,000 | 49.53 | 495,300 |
| 2025-02-24 | VCEL | Option Ex | 3,000 | .00 | 0 |
| 2024-12-02 | VCEL | Option Ex | 10,000 | 16.66 | 166,600 |
| 2024-12-02 | VCEL | Sale | 10,000 | 58.72 | 587,200 |
| 2024-09-03 | VCEL | Sale | 10,000 | 49.83 | 498,300 |
| 2024-09-03 | VCEL | Option Ex | 10,000 | 10.95 | 109,500 |
| 2024-05-20 | VCEL | Option Ex | 10,000 | 10.95 | 109,500 |
| 2024-05-20 | VCEL | Sale | 10,000 | 49.99 | 499,900 |
| 2024-02-20 | VCEL | Option Ex | 7,075 | .00 | 0 |
| 2024-02-12 | VCEL | Option Ex | 1,625 | .00 | 0 |
| 2023-11-20 | VCEL | Option Ex | 5,000 | 10.95 | 54,750 |
| 2023-11-20 | VCEL | Sale | 5,000 | 36.40 | 182,000 |
| 2023-02-18 | VCEL | Option Ex | 2,325 | .00 | 0 |
| 2023-02-19 | VCEL | Option Ex | 1,750 | .00 | 0 |
| 2023-02-11 | VCEL | Option Ex | 1,625 | .00 | 0 |
| 2023-02-06 | VCEL | Option Ex | 650 | .00 | 0 |
| 2022-03-01 | VCEL | Option Ex | 20,000 | 14.47 | 289,500 |
| 2022-03-01 | VCEL | Sale | 16,738 | 41.43 | 693,522 |
| 2022-02-19 | VCEL | Option Ex | 1,750 | .00 | 0 |
| 2022-02-11 | VCEL | Option Ex | 1,625 | .00 | 0 |
| 2022-02-06 | VCEL | Option Ex | 650 | .00 | 0 |
| 2021-12-22 | VCEL | Option Ex | 19,000 | 13.80 | 262,295 |
| 2021-12-20 | VCEL | Sale | 1,000 | 40.00 | 40,000 |
| 2021-12-20 | VCEL | Option Ex | 1,000 | 10.95 | 10,950 |
| 2021-12-22 | VCEL | Sale | 14,881 | 40.11 | 596,832 |
| 2021-03-30 | VCEL | Option Ex | 33,438 | 10.95 | 366,146 |
| 2021-03-30 | VCEL | Sale | 17,924 | 51.13 | 916,525 |
| 2021-02-11 | VCEL | Option Ex | 1,625 | .00 | 0 |
| 2021-02-06 | VCEL | Option Ex | 650 | .00 | 0 |
| 2020-12-21 | VCEL | Option Ex | 43,264 | 10.95 | 473,740 |
| 2020-12-21 | VCEL | Sale | 24,235 | 26.50 | 642,130 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hopper Jonathan Mark (Chief Medical Officer of Vericel Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.